# An Extension to Study MD7108240

> **NCT00733304** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 42 (actual)

## Conditions studied

- Macular Degeneration

## Interventions

- **DRUG:** Pazopanib

## Key facts

- **NCT ID:** NCT00733304
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06-25
- **Primary completion:** 2009-09-09
- **Final completion:** 2009-09-09
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2017-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00733304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00733304, "An Extension to Study MD7108240". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00733304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*